Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept
Download97 - 102 of 232 results
Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery
1 May 2021Application of Translational Pharmaceutics® in Accelerating the Development of MR Dosage Forms
1 April 2021Risk Based Monitoring from a Phase I Clinical Site Perspective
2 February 2021Scientific Paper_ Development of a Prototype, Once-Daily, Modified Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772
1 February 2021AAPS 2020 Poster: Flexible formulation assessments in FIH studies for poorly soluble drugs accelerates dosage form development, manufacturing and supply for patient POC trials
5 November 2020AAPS 2020 Poster: Development of High Drug Load Multiparticulate Beads Using an Extrusion-Spheronization Process
5 November 2020Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.